The role of small extracellular vesicle-miRNAs in endometriosis.

Autor: Nazri HM; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK., Greaves E; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK., Quenby S; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK., Dragovic R; Nuffield Department of Women's & Reproductive Health, Endometriosis CaRe Centre, University of Oxford, Oxford, UK., Tapmeier TT; Nuffield Department of Women's & Reproductive Health, Endometriosis CaRe Centre, University of Oxford, Oxford, UK.; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.; The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia., Becker CM; Nuffield Department of Women's & Reproductive Health, Endometriosis CaRe Centre, University of Oxford, Oxford, UK.

Publikováno v: Human reproduction (Oxford, England) [Hum Reprod] 2023 Dec 04; Vol. 38 (12), pp. 2296-2311.

Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target.

Autor: Tapmeier TT; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK. Thomas.Tapmeier@monash.edu.; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, 3168, Australia. Thomas.Tapmeier@monash.edu.; The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, 3168, Australia. Thomas.Tapmeier@monash.edu., Howell JH; School of Applied Sciences, University of Brighton, Brighton, BN2 4GJ, UK., Zhao L; Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, 250117, China., Papiez BW; Li Ka Shing Centre for Health Information and Discovery, Big Data Institute, Oxford, OX3 7LF, UK., Schnabel JA; School of Biomedical Imaging and Imaging Sciences, King's College London, London, SE1 7EU, UK.; Helmholtz Center Munich - German Center for Environmental Health, 85764, Neuherberg, Germany.; Faculty of Informatics and Institute for Advanced Study, Technical University of Munich, 85748, Garching, Germany., Muschel RJ; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Gal A; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK. A.Gal@brighton.ac.uk.; School of Applied Sciences, University of Brighton, Brighton, BN2 4GJ, UK. A.Gal@brighton.ac.uk.

Publikováno v: Oncogene [Oncogene] 2022 Nov; Vol. 41 (46), pp. 5032-5045. Date of Electronic Publication: 2022 Oct 14.

Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.

Autor: Tapmeier TT; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK. thomas.tapmeier@monash.edu krina.zondervan@wrh.ox.ac.uk.; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria 3168, Australia., Rahmioglu N; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Lin J; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.; Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong 510632, PR China., De Leo B; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Obendorf M; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Raveendran M; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA., Fischer OM; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Bafligil C; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK., Guo M; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK., Harris RA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA., Hess-Stumpp H; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Laux-Biehlmann A; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Lowy E; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Lunter G; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK., Malzahn J; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK., Martin NG; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia., Martinez FO; Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7YH, UK., Manek S; Department of Pathology, Oxford University Hospitals Foundation Trust, Oxford OX3 9DU, UK., Mesch S; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Montgomery GW; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia., Morris AP; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.; Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester M13 9PL, UK., Nagel J; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Simmons HA; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA., Brocklebank D; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Shang C; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK., Treloar S; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia., Wells G; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK., Becker CM; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK., Oppermann U; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK., Zollner TM; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany., Kennedy SH; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK., Kemnitz JW; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.; Department of Cell & Regenerative Biology and Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53706, USA., Rogers J; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Zondervan KT; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK. thomas.tapmeier@monash.edu krina.zondervan@wrh.ox.ac.uk.; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.

Publikováno v: Science translational medicine [Sci Transl Med] 2021 Aug 25; Vol. 13 (608).

Characterization of exosomes in peritoneal fluid of endometriosis patients.

Autor: Nazri HM; Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom., Imran M; Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom., Fischer R; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Heilig R; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Manek S; Department of Cellular Pathology, Oxford University Hospitals, Oxford, United Kingdom., Dragovic RA; Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom., Kessler BM; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Zondervan KT; Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Tapmeier TT; Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom. Electronic address: thomas.tapmeier@wrh.ox.ac.uk., Becker CM; Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.

Publikováno v: Fertility and sterility [Fertil Steril] 2020 Feb; Vol. 113 (2), pp. 364-373.e2.

The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.

Autor: Tapmeier TT; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom;, Moshnikova A; Physics Department, University of Rhode Island, Kingston, RI 02881;, Beech J; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom;, Allen D; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom;, Kinchesh P; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom;, Smart S; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom;, Harris A; Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom;, McIntyre A; Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom; Cancer Biology, Division of Cancer and Stem Cells, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom;, Engelman DM; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520 ruth.muschel@oncology.ox.ac.uk donald.engelman@yale.edu., Andreev OA; Physics Department, University of Rhode Island, Kingston, RI 02881;, Reshetnyak YK; Physics Department, University of Rhode Island, Kingston, RI 02881;, Muschel RJ; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom; ruth.muschel@oncology.ox.ac.uk donald.engelman@yale.edu.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2015 Aug 04; Vol. 112 (31), pp. 9710-5. Date of Electronic Publication: 2015 Jul 20.